EDE FederalFederal Decree-Law No.38 of 2024
Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.
Federal Decree-Law No.38 of 2024 is the official EDE identifier for “Federal Decree-Law No.38 of 2024 — complete Arabic official expression”. Federal Decree-Law No.38 of 2024 is the official identifier EDE uses for this instrument.
- Instrument
- Federal
- Full name
- Federal Decree-Law No.38 of 2024
- Category
- General
- Source publication
- Arabic
- Readable HTML
- 1 language version
- Published
- —
- Effective
- —
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Federal Decree-Law No.38 of 2024 — complete Arabic official expression
Complete eighty-eight-page Arabic official expression of Federal Decree-Law No.38 of 2024 concerning medical products, the pharmacy profession and pharmaceutical establishments, including its original chemical schedule. The instrument contains mixed product and establishment scopes; drug, veterinary and chemical provisions are preserved as source context without being applied to medical devices or IVD. This Arabic original is a separate expression of the same instrument as the held English version, not an alias or a new instrument. The full original images govern over the qualified native search layer. Article 17 alone does not supply the outstanding detailed transfer conditions or checklist; currentness and question coverage remain unverified.
Federal Decree-Law No.38 of 2024 is the official identifier EDE uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.